Adherence to prescribing guidelines in the primary prevention of cardiovascular disease and in the management of patients with type 2 diabetes in Qatar

Abstract of a paper from ESCP 40th International Symposium on Clinical Pharmacy. Clinical Pharmacy: Connecting Care and Outcomes in Dublin, Ireland, 19–21 October 2011. The prevalence of diabetes mellitus (DM) in the UK increased in 2009 to 4%, of which type-2 diabetes accounts for 85–95% of all cases. In Qatar the prevalence of DM among the adult Qatari population in 2008 was 16.7%; around four times higher than the prevalence in the UK. The aim of the study was to design and to apply a medication assessment tool (MAT) to determine the level of adherence to internationally recognised guideline recommendations in type-2 diabetes management and in primary prevention of cardiovascular disease (CVD) among type-2 diabetes patients, to quantify any gaps in guideline implementation